Shaperon
Latest round
- Series C
Last raised
- Oct 2020
Total raised
- $43M
Investors
- 11
About Shaperon
Founded in 2008 and headquartered in Seoul, South Korea, Shaperon is dedicated to the development of novel therapies for inflammation-related conditions., leads its efforts in biotechnology.Shaperon specializes in crafting advanced inflammasome inhibitors and Nanobody therapeutics, with key products including NuGel®, NuSepin®, Oral HY209, Saviximab®, and Papiliximab®.76 mn. The company aims to launch additional therapeutics by late 2025, with specific targets for growth in North America and Europe, leveraging its innovative portfolio to enhance its market presence.
Who invested in Shaperon
11 investors across 3 rounds
See all investors in Shaperon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shaperon
Who invested in Shaperon?
Shaperon has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shaperon raised?
Shaperon has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Shaperon last raise money?
Shaperon's most recent round on record is a Series C, in Oct 2020.
What does Shaperon do?
Founded in 2008 and headquartered in Seoul, South Korea, Shaperon is dedicated to the development of novel therapies for inflammation-related conditions.
Where is Shaperon headquartered?
Shaperon is headquartered in Seoul, South Korea.
Which VCs invest in companies like Shaperon?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shaperon's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Shaperon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.